ALPINE IMMUNE SCIENCES INC COM Stock (NASDAQ:ALPN), Quotes and News Summary

Q: What sector and industry does ALPINE IMMUNE SCIENCES INC COM (ALPN) operate in?

ALPINE IMMUNE SCIENCES INC COM is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ALPINE IMMUNE SCIENCES INC COM Stock (NASDAQ: ALPN) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / -
Day Range	- - -
52 Wk Range	- - -
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	1.34

Recent News

$100B Vertex Pharma Working To Recreate $10B Cystic Fibrosis Success - This Time Focused On Pain Management Drugs

Unlock Vertex Pharmaceuticals' pioneering treatments, from the groundbreaking Trikafta for cystic fibrosis to the promising non-opioid painkillers.

Vandana Singh

Vertex's Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept's Potential Impact

Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9 billion, expanding into nephrology with promising APOL1-mediated kidney disease treatments. Analysts foresee significant revenue growth potential, with Alpine's lead molecule poised to add over $5 billion in sales.

Vandana Singh

Stocks Bounce Back With Tech, Gold Gaining After Modest Producer Inflation Data: What's Driving Markets Thursday?

Investors can breathe a sigh of relief on Thursday as last month’s Producer Price Index (PPI) inflation turned out slightly lower than expected, albeit with some caveats across different measures within the basket.

Piero Cingari

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating

2.7

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy ALPINE IMMUNE SCIENCES INC COM (ALPN) stock?

You can purchase shares of ALPINE IMMUNE SCIENCES INC COM (NASDAQ: ALPN) through any online brokerage.

View our list of the best stock brokerages.

Who are ALPINE IMMUNE SCIENCES INC COM's (ALPN) competitors?

There are no as such competitors for ALPINE IMMUNE SCIENCES INC COM.

What is the target price for ALPINE IMMUNE SCIENCES INC COM (ALPN) stock?

The latest price target for ALPINE IMMUNE SCIENCES INC COM (NASDAQ: ALPN) was reported by Wedbush on Thursday, May 16, 2024. The analyst firm set a price target for 65.00 expecting ALPN to rise to within 12 months (a possible 0.02% upside). 30 analyst firms have reported ratings in the last year.

Current Stock Price for ALPINE IMMUNE SCIENCES INC COM (ALPN)?

The stock price for ALPINE IMMUNE SCIENCES INC COM (NASDAQ: ALPN) is $64.99 last updated May 17, 2024 at 7:22 PM EDT.

Does ALPINE IMMUNE SCIENCES INC COM (ALPN) pay a dividend?

There are no upcoming dividends for ALPINE IMMUNE SCIENCES INC COM.

When is ALPINE IMMUNE SCIENCES INC COM (NASDAQ:ALPN) reporting earnings?

ALPINE IMMUNE SCIENCES INC COM’s Q2 earnings are confirmed for Monday, August 12, 2024.

Is ALPINE IMMUNE SCIENCES INC COM (ALPN) going to split?

There is no upcoming split for ALPINE IMMUNE SCIENCES INC COM.

What sector and industry does ALPINE IMMUNE SCIENCES INC COM (ALPN) operate in?

ALPINE IMMUNE SCIENCES INC COM is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.